Cobalt Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.8M Buy
+15,000
New +$5.56M 4.13% 9
2025
Q1
Sell
-15,000
Closed -$5.53M 27
2024
Q4
$5.53M Buy
+15,000
New +$6.28M 2.3% 12
2016
Q4
Sell
-141,449
Closed -$17.7M 52
2016
Q3
$17.7M Sell
141,449
-176,203
-55% -$22.8M 2.69% 12
2016
Q2
$41.7M Buy
317,652
+62,889
+25% +$8.6M 5.55% 4
2016
Q1
$35.4M Buy
254,763
+80,325
+46% +$10.7M 4.46% 7
2015
Q4
$24.3M Buy
174,438
+90,423
+108% +$12.5M 3.12% 12
2015
Q3
$11.8M Buy
+84,015
New +$12.6M 1.14% 37

Other funds holding ELV

Cobalt Capital Management's ELV Position: Q2 2026 in Review

Cobalt Capital Management opened a new position in Elevance Health (ELV) in Q2 2026: 15,000 shares worth $5.8M. The stake represents 4.13% of the portfolio and ranks #9 among its holdings. This is a return to the name: Cobalt Capital Management previously reported a position in ELV as recently as Q4 2024.

Cobalt Capital Management first reported a position in ELV in Q3 2015 and has held it in 7 quarters since. The position peaked at $41.7M in Q2 2016. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cobalt Capital Management held 15,000 shares of Elevance Health worth $5.8M as of Q2 2026.
  • Elevance Health was a new Cobalt Capital Management position in Q2 2026.
  • Elevance Health made up 4.13% of Cobalt Capital Management's portfolio in Q2 2026, its #9 holding.
  • Cobalt Capital Management first reported a position in Elevance Health in Q3 2015 and has held it in 7 quarters since.
  • Cobalt Capital Management's Elevance Health position peaked at $41.7M in Q2 2016.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cobalt Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.